EA200601438A1 - Аморфные формы мононатриевой соли ризедроновой кислоты - Google Patents

Аморфные формы мононатриевой соли ризедроновой кислоты

Info

Publication number
EA200601438A1
EA200601438A1 EA200601438A EA200601438A EA200601438A1 EA 200601438 A1 EA200601438 A1 EA 200601438A1 EA 200601438 A EA200601438 A EA 200601438A EA 200601438 A EA200601438 A EA 200601438A EA 200601438 A1 EA200601438 A1 EA 200601438A1
Authority
EA
Eurasian Patent Office
Prior art keywords
salt
acid
riedric
mononatric
amorphous forms
Prior art date
Application number
EA200601438A
Other languages
English (en)
Other versions
EA009737B1 (ru
Inventor
Индрих Рихтер
Йосеф Ирман
Гана Петрицкова
Original Assignee
Зентива А.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34915827&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200601438(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CZ20040292A external-priority patent/CZ298383B6/cs
Priority claimed from CZ20040798A external-priority patent/CZ298328B6/cs
Priority claimed from CZ20040880A external-priority patent/CZ298491B6/cs
Application filed by Зентива А.С. filed Critical Зентива А.С.
Publication of EA200601438A1 publication Critical patent/EA200601438A1/ru
Publication of EA009737B1 publication Critical patent/EA009737B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Новые аморфные формы мононатриевой соли 3-пиридил-1-гидроксиэтилиден-1,1-бисфосфоновой кислоты, способы их получения и фармацевтический препарат на их основе.
EA200601438A 2004-02-26 2005-02-28 Аморфные формы мононатриевой соли ризедроновой кислоты EA009737B1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CZ20040292A CZ298383B6 (cs) 2004-02-26 2004-02-26 Amorfní forma risedronátu monosodného
CZ20040798A CZ298328B6 (cs) 2004-07-08 2004-07-08 Semikrystalická forma risedronátu monosodného, zpusob jeho prípravy a léková forma ho obsahující
CZ20040880A CZ298491B6 (cs) 2004-08-12 2004-08-12 Zpusob prípravy amorfní formy risedronátu monosodného
PCT/CZ2005/000024 WO2005082915A1 (en) 2004-02-26 2005-02-28 Amorphous forms of risedronate monosodium

Publications (2)

Publication Number Publication Date
EA200601438A1 true EA200601438A1 (ru) 2006-12-29
EA009737B1 EA009737B1 (ru) 2008-02-28

Family

ID=34915827

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601438A EA009737B1 (ru) 2004-02-26 2005-02-28 Аморфные формы мононатриевой соли ризедроновой кислоты

Country Status (8)

Country Link
US (1) US7618953B2 (ru)
EP (1) EP1723157B2 (ru)
DE (1) DE602005003557D1 (ru)
EA (1) EA009737B1 (ru)
PL (2) PL1723157T5 (ru)
SK (1) SK50782006A3 (ru)
UA (1) UA83900C2 (ru)
WO (1) WO2005082915A1 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005001873T2 (de) 2004-03-03 2008-04-24 Chemi S.P.A., Cinisello Balsamo Amorphe 3-Pyridyl-1-Hydroxyethyliden-1,1-Bisphosphonsäure Mononatriumsalz und Verfahren zu deren Herstellung
CA2582449A1 (en) * 2004-09-30 2006-04-13 Dr. Reddy's Laboratories Ltd. Amorphous atorvastatin calcium
WO2006134603A1 (en) * 2005-06-13 2006-12-21 Jubilant Organosys Limited Process for producing bisphosphonic acids and forms thereof
GB0519891D0 (en) * 2005-09-30 2005-11-09 Pliva Hrvatska D O O Pharmaceutically acceptable salts and hydrates
JP5354858B2 (ja) * 2006-05-09 2013-11-27 株式会社Ａｄｅｋａ スルホンアミド化合物の金属塩を含有するポリエステル樹脂組成物
EP2016084A2 (en) 2006-05-11 2009-01-21 Ind-Swift Laboratories Limited Process for the preparation of pure risedronic acid or salts
KR100775440B1 (ko) * 2006-12-20 2007-11-12 동우신테크 주식회사 리세드로네이트 나트륨 헤미펜타히드레이트의 제조방법
DE102007030370A1 (de) 2007-06-29 2009-01-02 Ratiopharm Gmbh Essigsäure-Solvate von Risedronat, Polymorph hiervon, deren Herstellung und Verwendung sowie pharmazeutische Zusammensetzung, enthaltend diese
KR101010062B1 (ko) 2008-04-11 2011-01-21 주식회사 대희화학 증발 결정화를 이용한 결정상 리세드로네이트 모노소듐모노하이드레이트의 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1378234A1 (en) † 1996-05-17 2004-01-07 MERCK & CO. INC. Effervescent bisphosphonate formulation
KR19990001564A (ko) 1997-06-16 1999-01-15 유충식 용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
ATE293450T1 (de) † 1999-05-21 2005-05-15 Novartis Pharma Gmbh Verwendung von biphosphonsäuren zur behandlung von angiogenese
PE20011061A1 (es) * 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
GB2383042A (en) † 2001-10-18 2003-06-18 Cipla Ltd Amorphous alendronate sodium
WO2003086355A1 (en) † 2002-04-11 2003-10-23 Teva Pharmaceutical Indudstries, Ltd. Novel polymorphs and pseudopolymorphs of risedronate sodium
CZ20023574A3 (en) 2002-10-25 2004-04-14 Léčiva, A.S. New crystalline form of the sodium salt of 3-pyridyl-1-hydroxyehtylidene-1,1-bisphosphonic acid
CZ298639B6 (cs) † 2004-02-05 2007-12-05 Zentiva, A. S. Krystalická forma risedronátu monosodného
DE602005001873T2 (de) † 2004-03-03 2008-04-24 Chemi S.P.A., Cinisello Balsamo Amorphe 3-Pyridyl-1-Hydroxyethyliden-1,1-Bisphosphonsäure Mononatriumsalz und Verfahren zu deren Herstellung
WO2006134603A1 (en) † 2005-06-13 2006-12-21 Jubilant Organosys Limited Process for producing bisphosphonic acids and forms thereof

Also Published As

Publication number Publication date
US7618953B2 (en) 2009-11-17
PL1723157T5 (pl) 2018-01-31
EP1723157A1 (en) 2006-11-22
EA009737B1 (ru) 2008-02-28
DE602005003557D1 (de) 2008-01-10
PL1723157T3 (pl) 2008-04-30
PL213481B1 (pl) 2013-03-29
WO2005082915A1 (en) 2005-09-09
EP1723157B2 (en) 2017-02-08
UA83900C2 (en) 2008-08-26
EP1723157B1 (en) 2007-11-28
SK50782006A3 (sk) 2007-03-01
PL380663A1 (pl) 2007-02-19
US20070142332A1 (en) 2007-06-21

Similar Documents

Publication Publication Date Title
EA200601438A1 (ru) Аморфные формы мононатриевой соли ризедроновой кислоты
EA201000883A1 (ru) Производные индолинона и способ их получения
EA201001402A1 (ru) Фармацевтические растворы, способ получения и терапевтическое применение
CY1111729T1 (el) Υπογλωσσιο επικαλυμμενο δισκιο
ATE405570T1 (de) Hiv-integrase-inhibitoren: cyclische pyrimidinonverbindung
DK1896006T3 (da) Fremstillingmetode for entacapon-holdige granuler til orale doseringsformet
EA200970149A1 (ru) Производные n-(аминогетероарил)-1h-индол-2-карбоксамидов, их получение и их применение в терапии
EA200602099A1 (ru) Получение прегабалина и родственных соединений
RS52108B (en) 3-SUBSTITUTED [1,2,3] -BENZOTRIAZINONE UNIT TO INCREASE GLUTAMATERGIC SYNAPTIC ANSWERS
EA201071099A1 (ru) СОЛЕВЫЕ ФОРМЫ ИНГИБИТОРА mTOR
EA200500673A1 (ru) Аморфная форма соли эзомепразола, способ ее получения и фармацевтическая композиция на её основе
DK1663989T3 (da) Krystallisk form af bis(E)-7-[4(4-fluorphenyl)-6-isopropyl-2-methyl(methylsulfonyl)aminopyrimidin-5-yl(3R,5S))-3-5-dihydroxyhept-6-ensyrecalciumsalt
DK1641438T3 (da) Fremgangsmåde til fremstilling af den amorfe form af et lægemiddel
EA200800502A1 (ru) Соединения 3-аминокарбазола, фармацевтическая композиция, содержащая указанные соединения, и способ их получения
CY1117753T1 (el) Κρυσταλλικη μορφη του αλατος αργινινης της περινδοπριλης, μεθοδος παρασκευης της και φαρμακευτικες συνθεσεις οι οποιες την περιεχουν
DE602004013405D1 (de) Polymorphe formen von valsartan
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
EA200700637A1 (ru) Соли донепезила, подходящие для получения фармацевтических композиций
EA201170983A1 (ru) Производные тиадиазолов и оксадиазолов, их получение и их применение в терапии
EA200800324A1 (ru) Новый способ получения солей тиотропия
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
EA200700766A1 (ru) Способ получения производных [1,4,5]-оксадиазепина
EA200900780A1 (ru) Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства
CY2011018I1 (el) Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος
EA200802248A1 (ru) Способы применения соединений 4-амино-5-хлортиено[2,3-d]-пиримидина в качестве инсектицидов

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KG MD TJ TM